FIMM has a driving mission to perform innovative research on patients and populations targeted towards understanding drivers of health and disease. We aim at delivering improvements to the safety, efficacy, and efficiency of healthcare in Finland and beyond.
We are inviting outstanding candidates for the position of Group Leader in Molecular Medicine with an initial 5-year appointment and the opportunity for a 4-year extension following the EMBL model.
This group leader search is for 2-3 early-stage group leaders with significant international experience during their PhD and postdoc periods. The candidates should provide novel and complementary contributions to existing research at FIMM and the University of Helsinki more broadly.
The call is open until September 6, 2023.
FIMM is proud to host the 12th annual meeting of Nordic EMBL Partnership, in Helsinki from 11-14th September 2023. The program will consist of high-quality scientific presentations, poster sessions and interesting social activities. This event also aims to equip the scientists with new skills and encourages multidisciplinary interaction among the researchers.
This new brochure describes some of our main scientific projects and achievements during the past few years and covers our key statistics. It also provides detailed information about our research programmes, infrastructure platforms, research training and other important aspects of FIMM.
As a translational institute, FIMM drives human-based research that has a profile of excellence at the highest level globally in terms of traditional metrics of publication, as well as leadership of international research efforts. We aim for our research to deliver, in a local context, direct health impact by bringing the results of research efforts to the Finnish population. Within the field of molecular medicine, FIMM focuses on ‘Grand Challenges’ that pursue our overall mission.